RareStone Group is dedicated to building the first rare disease ecosystem in the Greater China, to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable service supports. Our mission is to become the leading company supporting the rare disease community in China. We aim to build the first rare disease ecosystem in China to bring a support network and much needed treatments to individuals and their families affected by rare diseases.
RareStone Group consists of two business subsidiaries: Citrine Medicine and Zircon Health. Citrine Medicine is a pharmaceutical company and focused on providing effective and affordable therapeutic solutions to rare disease patients in the Greater China. Zircon Health is a “service company” and aims to build the first ecosystem for rare disease in China, providing a patient-centered service platform for full disease management.